Healthy Donors

15 registered clinical trials studyying Healthy Donors — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Bioequivalence Study of Clonazepam 2 Mg Tablets NCT06834503	Centro de Atencion e Investigacion Medica	Phase 4
Active Not Recruiting	Bioequivalence Study of Revolade® Eltrombopag 50 mg NCT06834451	Centro de Atencion e Investigacion Medica	Phase 4
Not Yet Recruiting	Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions NCT06823362	Centro de Atencion e Investigacion Medica	Phase 4
Recruiting	Investigating the Impact of the Seaweed Derived Food Additive, Carrageenan, on the Human Gut Microbiome NCT06738329	University of Reading	N/A
Completed	Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Effi NCT06905847	Haisco Pharmaceutical Group Co., Ltd.	Phase 1
Completed	T-TAS® wS Method Comparison NCT06710262	Hikari Dx, Inc.	—
Active Not Recruiting	Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects NCT06861842	Centro de Atencion e Investigacion Medica	Phase 4
Recruiting	Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy) NCT06842407	Checkmab S.r.l.	—
Unknown	CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healt NCT06727383	European Institute of Oncology	N/A
Completed	Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE) NCT05141383	Institut Curie	N/A
Terminated	MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies NCT04762875	Ensoma	Phase 2
Completed	Living Donor Liver Transplantation in Children NCT02124382	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	—
Recruiting	A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor NCT00571389	BioCytics, Inc.	—
Completed	Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay NCT00686205	Abbott Diagnostics Division	Phase 3
Enrolling By Invitation	Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick NCT00339911	National Cancer Institute (NCI)	—